Erasca Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Erasca does not have a record of paying a dividend.

Wichtige Informationen

n/a

Dividendenausschüttung

-28.5%

Rückkaufsrendite

Gesamte Aktionärsrendite-28.5%
Zukünftige Dividendenrendite0%
Wachstum der Dividenden/a
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Ausschüttungsquoten/a

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Oct 15
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Erasca: New Focus After Restructuring, But Need More Differentiation

Sep 30

Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?

Feb 21
Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?

We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully

Nov 16
We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully

Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth

Jun 28
Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth

We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Jan 20
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth

Erasca forms clinical trial partnership with Pfizer for cancer therapy

Oct 20

Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Sep 23
Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Erasca adds 10% ahead of R&D Day

Sep 07

Erasca, Eli Lilly to collaborate on trial to evaluate combo treatment for two cancers

Jul 18

We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate

Apr 12
We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate

Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Dec 28
Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Insufficient data to determine if ERAS's dividends per share have been stable in the past.

Wachsende Dividende: Insufficient data to determine if ERAS's dividend payments have been increasing.


Dividendenrendite im Vergleich zum Markt

Erasca Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von ERAS im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (ERAS)n/a
Untere 25 % des Marktes (US)1.5%
Markt Top 25 % (US)4.5%
Branchendurchschnitt (Biotechs)2.2%
Analystenprognose (ERAS) (bis zu 3 Jahre)0%

Bemerkenswerte Dividende: Unable to evaluate ERAS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hohe Dividende: Unable to evaluate ERAS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Insufficient data to calculate ERAS's payout ratio to determine if its dividend payments are covered by earnings.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Unable to calculate sustainability of dividends as ERAS has not reported any payouts.


Entdecken Sie dividendenstarke Unternehmen